AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

NUFORMIX PLC

Director's Dealing Sep 28, 2018

4941_dirs_2018-09-28_328d0924-09e4-4881-9477-71dff6c484e6.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3235C

Nuformix PLC

28 September 2018

28 Setember 2018

Nuformix plc

("Nuformix" or the "Company")

PDMR

The Company was notified on 28 September 2018 that Kirk Siderman-Wolter, Non-Executive Director of the Company, bought 35,364 Nuformix plc ordinary shares of 0.1p each ("Shares") at a purchase price of 2.6p per share.

Following this transaction he holds 35,364 shares, representing 0.00077% of the issued share capital of the Company.

1 Details of the person discharging managerial responsibilities.
a) Name Kirk  Siderman-Wolter
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Nuformix plc
b) LEI 2138003XG3H3I2J3BJ24
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.1p each
Identification code GB00BYW79Y38
b) Nature of the transaction Acquisition of ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
2.6p 35,364
d) Aggregated information
- Aggregated volume 35,364
- Price 2.6p
e) Date of the transaction 16.08.18
f) Place of the transaction Standard List, London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHPGURUBUPRUBR

Talk to a Data Expert

Have a question? We'll get back to you promptly.